[CONTRIBUTION TO THE ETIOLOGY, PROGNOSIS AND TREATMENT OF LIVER CIRRHOSIS AND CHRONIC HEPATITIS. THERAPEUTIC EXPERIMENT WITH A COMBINED VITAMIN PREPARATION].
D000437:Alcoholism; D001205:Ascorbic Acid / Q000627:therapeutic use*; D004358:Drug Therapy; D005492:Folic Acid; D006505:Hepatitis; D006506:Hepatitis A; D006521:Hepatitis, Chronic; D006801:Humans; D008103:Liver Cirrhosis; D008111:Liver Function Tests; D009525:Niacin; D009536:Niacinamide; D009945:Organotherapy; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D014116:Toxicology; D014805:Vitamin B 12; D014815:Vitamins
D014815:Vitamins; D009536:Niacinamide; D009525:Niacin; D005492:Folic Acid; D014805:Vitamin B 12; D001205:Ascorbic Acid; D011241:Prednisone
ALCOHOLISM; ASCORBIC ACID, THERAPEUTIC; DRUG THERAPY; FOLIC ACID; HEPATITIS, INFECTIOUS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; NICOTINAMIDE; ORGANOTHERAPY; PREDNISONE, THERAPEUTIC; TOXICOLOGIC REPORT; VITAMIN B 12
BEITRAG ZUR ATIOLOGIE, PROGNOSE UND THERAPEUTISCHEN BEEINFLUSSBARKEIT VON LEBERCIRRHOSE UND CHRONISCHER HEPATITIS. BEHANDLUNGSVERSUCHE MIT EINEM VITAMIN-KONBINATIONSPRAEPARAT.